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Abstract 
Community pharmacies have great potential to deliver services aimed at promoting health 
and preventing disease, and are well placed in deprived communities. This review of reviews 
aimed to assess the effectiveness of community pharmacy-delivered public health services and 
assess how they impact on inequalities in health using PROGRESS-Plus characteristics. Twenty 
databases were searched from their start date until January 2018. The quality of the included 
articles was determined using the Assessment of Multiple Systematic Reviews tool (AMSTAR 2). 
Fifteen systematic reviews were identified reporting 157 unique primary studies. There were a 
number of community pharmacy initiatives with positive intervention effects on health outcomes. 
These services were predominantly focused on primary disease prevention, and included smoking 
cessation, weight management programmes, syringe exchange programmes, and inoculation 
services. This review supports the development of some community pharmacy public health 
services.  At present, little is known how community pharmacy-delivered public health 
interventions impact on health inequalities. It would be prudent for future studies to address this 
by explicitly reporting outcomes according to the PROGRESS-Plus framework. 
Systematic review registration 
PROSPERO registration number: CRD42017056264 
 
Keywords 
Community pharmacy 
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Health promotion 
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1. Background 
Community pharmacies have emerged as strategically important settings that have great 
potential to deliver services aimed at promoting health, and preventing disease. In many 
countries, the community pharmacist is the most accessible healthcare provider to the general 
public: they are available without an appointment, are open evenings and weekends, and are 
often located in the most deprived communities (the ‘positive pharmacy care law’ (Todd et al., 
2014)). Community pharmacies are thereby ideally placed to offer public health and healthcare 
services to the most deprived communities.  
In recent decades, the role of the community pharmacist has undergone rapid expansion, 
with many services moving away from the traditional supply function to more patient-focussed 
services (Anderson, 2007). Indeed, many community pharmacists now offer a range health 
promotion activities aimed at either primary or secondary disease prevention. Accompanying this 
shift, the literature surrounding the extended role of the community pharmacist has also 
expanded – with many groups producing systematic reviews examining the effectiveness of such 
interventions (Brown et al., 2016). Previous systematic reviews have predominantly focused on 
single interventions, and have not explored intervention effectiveness at the primary or secondary 
prevention level, making it challenging to determine where community pharmacy-delivered 
interventions fit within the wider disease prevention agenda. At present, there is no 
comprehensive review that seeks to examine the effectiveness of all community pharmacy-
delivered public health services, or explore how the effects of these services are moderated by 
socio-demographic factors. This later point has been highlighted by the UK National Institute of 
Health and Care (NICE) as a research priority to ensure the potential of community pharmacy-
delivered public health interventions in reducing health inequalities can be maximised (NICE, 
2018). A wide, and comprehensive, review of community pharmacy-delivered public health 
interventions is needed to inform policy, but also to identify gaps and inform future research 
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endeavours. In this paper, we undertake a ‘review of reviews’ of community pharmacy-delivered 
public health services and seek to determine how they impact on health and inequalities in health. 
A review of reviews is an established and effective way of bringing together and summarising a 
broad evidence-base (Becker and Oxman, 2008) and have been used for a number of public health 
topics (Bambra et al., 2010; Cairns et al., 2015; Hill et al., 2014; Main et al., 2008).  
 
2. Methods 
The full methodology for this work has been previously described in the published protocol 
(Hillier-Brown et al., 2017). The review is also registered with PROSPERO (CRD42017056264), while 
a completed PRISMA checklist is also included in Appendix S1. 
 
Research questions 
1. What is the effectiveness of community pharmacy-delivered public health interventions? 
2. How are the intervention effects moderated according to PROGRESS-Plus factors? 
 
Inclusion criteria 
Following standard evidence synthesis approaches (Kavanagh et al., 2008), the inclusion 
criteria for the review were determined a priori in terms of PICOS (Population, Intervention, 
Comparison, Outcome and Study design (Higgins and Green, 2011)).  
 
 Population: Children and adults (all ages) in any country.  
 
 Intervention: Public health interventions delivered in community pharmacy settings. For 
the purposes of the review, a public health intervention was described as any intervention 
designed to prevent disease, promote health and prolong life; specifically, we focused on 
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interventions aimed at the primary prevention (preventing the onset of disease) or 
secondary prevention level (detecting disease in the early stages). A community pharmacy 
was defined as a pharmacy set in the community, which is accessible to all and not based in 
a hospital, clinic or GP surgery. 
 
 Comparison: Systematic reviews that included studies with and without controls, including 
randomized and nonrandomized controlled trials, randomized and nonrandomized cluster 
trials, prospective and retrospective cohort studies (with and/or without control groups), 
prospective repeat cross-sectional studies (with and/or without control groups) and 
interrupted time series analysis (with and/or without control groups).  
 
 Outcomes: To answer our primary research question, we included health outcome data, 
and to answer our secondary research question, we included health inequality outcomes. 
Primary outcomes included health outcomes, physiology and biochemical outcomes, and 
behavioural outcomes. Secondary outcomes related to how the effects of the interventions 
were moderated in terms of PROGRESS-Plus factors: place of residence, race/ethnicity, 
occupation, gender, religion, education, socio-economic status (defined as: individual 
income, wealth, education, employment or occupational status, benefit receipt; as well as 
area-level economic indicators), social capital, age, disability and sexual orientation . When 
available, cost effectiveness data was also collected.  
 
 Study design: Only systematic reviews were included in the analysis. Following the 
methods of previous review of reviews (Bambra et al., 2010; Cairns et al., 2015), 
publications needed to meet two of the three mandatory criteria of Database of Abstracts 
of Reviews of Effects (DARE): (i) that there is a defined review question (with definition of 
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at least two of, the participants, interventions, outcomes or study designs) and (ii) that the 
search strategy included at least one named database, in conjunction with either reference 
checking, hand-searching, citation searching or contact with authors in the field.  
 
Exclusion criteria 
We excluded interventions that focused on promoting medicine adherence, or medicine 
optimisation; we also excluded any intervention aimed at tertiary disease prevention (reducing 
symptoms of an established disease). 
 
Search strategy 
Twenty databases were searched until January 2018 (host sites given in parentheses): 
Medline (Ovid), Embase (Ovid), Cumulative Index to Nursing and Allied Health Literature (CINAHL; 
EBSCOhost), PsycINFO (EBSCOhost), Social Science Citation Index (Web of Science), Applied Social 
Sciences Index and Abstracts (ASSIA; ProQuest), International Bibliography of the Social Sciences 
(IBSS; ProQuest), Sociological Abstracts (ProQuest), Social Services Abstracts (ProQuest), Prospero 
(Centre for Reviews and Dissemination, University of York), Campbell Collaboration Library of 
Systematic Reviews (The Campbell Library), Cochrane Library (includes Cochrane Database of 
Systematic Reviews, Cochrane Central Register of Controlled Trials, Cochrane Methodology 
Register, Database of Abstracts of Reviews of Effects, Health Technology Assessment Database, 
NHS Economic Evaluation Database; Wiley), Database of Promoting Health Effectiveness Reviews 
(DoPHER; EPPI-Centre), Social Care Online (SCIE) and Health Systems Evidence.  
Searches were tailored to the specific host site (full search strategies are shown in 
Appendix S2). In addition, citation follow up from the bibliographies and reference lists of all 
included articles was conducted. Searches were limited to peer-reviewed publications only. No 
language or publication date restrictions were applied. Authors were contacted to obtain relevant 
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information that was missing. If systematic reviews did not have sufficient data, they were 
excluded from further analysis. 
 
Study selection, data extraction and quality appraisal 
Study selection was conducted by three reviewers independently with cross-checking (FHB, 
NW, KT). Agreement between the reviewers was 99% with a kappa score of good (κ = 0.68) 
(Higgins and Deeks, 2011). The methods and main findings were extracted using a bespoke data 
extraction form (detailed in Appendix S3). The quality of each systematic review was determined 
using the updated version of the Assessment of Multiple Systematic Reviews: AMSTAR 2 (Shea et 
al., 2017). Data extraction and quality appraisal was conducted by three reviewers (KT, FHB and 
NW) and checked in full by KT or AT. Any discrepancies were resolved through discussion and 
consensus.  
 
Data synthesis 
The systematic reviews were narratively synthesised by intervention type. Effect sizes from 
meta-analyses were considered when available.  
 
3. Results 
A total of 16,827 citations were retrieved from the twenty databases searched. 
Deduplication resulted in 12,066 unique citations. Reasons for exclusion at the full text stage are 
detailed in Appendix S4. In total, 15 systematic reviews (Tables 1-8) were included in our review, 
reporting 157 unique primary studies (Figure 1).  
 
[INSERT FIGURE 1 HERE] 
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Assessment with AMSTAR2 revealed: two reviews had one weakness (Elias et al., 2011; 
Sinclair et al., 2004), three reviews had two weaknesses (Brown et al., 2016; Gordon et al., 2011; 
Sawangjit et al., 2016), three reviews had three weaknesses (Blenkinsopp et al., 2003; Gudka et al., 
2013; Lindsey et al., 2015), three reviews had four critical domain weaknesses (Ayorinde et al., 
2013; Saba et al., 2014; Watson and Blenkinsopp, 2009), while four reviews (Burson et al., 2016; 
Kapadia, 2013; Nacopoulos et al., 2010; Nguyen, 2017) had weaknesses in five out of the seven 
possible critical domains (no reviews had zero critical domain weaknesses) (Appendix S5).  
The reviews covered six different public health intervention areas. Interventions aimed at 
primary prevention included: smoking cessation (n=2) (Saba et al., 2014; Sinclair et al., 2004); 
weight management (n=1) (Gordon et al., 2011); alcohol misuse (n=1) (Watson and Blenkinsopp, 
2009); syringe/needle exchange programmes (n=2) (Nacopoulos et al., 2010; Sawangjit et al., 
2016); inoculation services (n=1) (Burson et al., 2016). Two of the included reviews were multi-
component, exploring a range of public health interventions (n=2) (Blenkinsopp et al., 2003; 
Brown et al., 2016). Interventions aimed at secondary prevention included those directed at 
screening services, which ranged from cancer to osteoporosis screening (n=4) (Ayorinde et al., 
2013; Elias et al., 2011; Lindsey et al., 2015; Nguyen, 2017), and chlamydia testing (Gudka et al., 
2013; Kapadia, 2013). Seven of the reviews looked at health inequalities (Brown et al., 2016; 
Burson et al., 2016; Elias et al., 2011; Gudka et al., 2013; Kapadia, 2013; Lindsey et al., 2015; 
Nacopoulos et al., 2010) and 16% of primary studies were reported in more than one systematic 
review (see Appendix S6).  
 
Primary Prevention 
Smoking cessation 
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Two reviews (reporting five unique studies), focused on smoking cessation interventions 
and included a combination of advice, education or nicotine replacement therapy (NRT). Both 
reviews showed improvements in health as measured by cessation rates (Table 1). The first review 
by Sinclair et al. (Sinclair et al., 2004), found two relevant primary studies, both of which were 
RCTs conducted in the UK. These studies compared a support programme of counselling with a 
control group who received normal service from community pharmacy personnel. Both studies 
reported an improvement in self-reported cessation rates: one study reported at 12 months 
(14.3% versus 2.7%, p<0.001), while the other study showed a positive outcome at 9 months 
(12.0% versus 7.4%, p=0.09).  
The second review, a meta-analysis by Saba et al. (2014), also assessed the effectiveness of 
smoking cessation interventions in community pharmacies. It included five relevant studies (three 
RCTs and two controlled before and after studies) from the USA, UK and Sweden. The 
interventions in these studies provided advice and counselling to patients, either on a one-to-one 
basis or in group sessions. The results suggested that smoking cessation interventions delivered by 
community pharmacists resulted in better abstinence rates when compared with controls (RR 
2.17, 95% CI 1.43-3.31). There was also evidence that the use of NRT alongside counselling yielded 
higher abstinence rates (RR 3.46, 95% CI 1.66, 7.23).  
 
Weight management 
A systematic review by Gordon et al. (2011) explored the effectiveness of community 
pharmacy-delivered weight management interventions (Table 2) and concluded there was 
insufficient evidence for their effectiveness. Of the 10 primary studies included, one was also 
reported in the multi-component review, undertaken by Brown et al. (2016). Studies from this 
review were conducted in the USA, UK, Switzerland, Spain and Denmark. All of the interventions 
included in this review had multiple components and focused on dietary advice, improving 
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physical activity, meal replacement, or using pharmacotherapy to promote weight loss. Overall, 
modest, but significant, weight loss amongst participants was reported in all of the studies, 
although the review acknowledged the included studies had reporting and methodological 
weaknesses. In view of this, the authors of the review concluded that there was insufficient 
evidence for the effectiveness and cost effectiveness of community pharmacy-based weight 
management initiatives to support investment in their provision.  
 
Alcohol misuse 
A single review by Watson and Blenkinsopp (2009) examined the feasibility of providing 
community pharmacy-based services for alcohol misuse (Table 3). The review included two 
relevant primary studies conducted in the UK that used approaches to identify hazardous and 
harmful drinking. Both studies found non-significant reductions in alcohol consumption following 
brief interventions.  
 
Syringe/needle exchange programmes 
Two reviews examined the impact of syringe/needle exchange programmes (SEPs) based in 
community pharmacies for intravenous drug users (Table 4), and showed a clear effect in 
improving health outcomes. In total, twenty-eight unique primary studies were identified by the 
two reviews (one study was duplicated in both reviews).  
The first review, by Nacopoulos et al. (2010), which synthesised evidence from 16 primary 
studies conducted in the USA, concluded that such interventions can have a positive effect on 
health outcomes by reducing high-risk injecting behaviours. The work also demonstrated that 
people using SEPs had lower rates of injection frequency, unemployment, jail time, homelessness, 
smoking, and alcohol use compared with intravenous drug users who do not participate in SEPs.  
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The second review, by Sawangjit et al. (2016), included evidence from thirteen studies – 
the majority of which were undertaken in the USA, although studies from the UK, Australia, 
Estonia, and Canada were also included. The review found that community pharmacy-based SEPs 
were effective in reducing high-risk behaviours among intravenous drug users (e.g. syringe-sharing 
behaviour). When only higher quality studies were considered, syringe-sharing behaviour was 
significantly better in community pharmacy-based SEPs compared to no SEPs (OR = 0.52; 95% CI = 
0.32, 0.84; I2 = 41.4%).  
 
Inoculation services  
One systematic review examined the health effects of inoculation services offered by 
community pharmacies (Table 5). The review, by Burson et al. (2016), concluded that pharmacy-
based immunisation interventions are capable of improving access to immunisation services, 
which has the potential to increase vaccination rates. In total, seventeen primary studies included 
in this review were relevant to our review; sixteen of the studies were conducted in the USA, and 
one was conducted in Puerto Rico. Most notably, community pharmacy-based services were 
effective in increasing influenza vaccination rates among people who had missed vaccination the 
previous year, or would have not otherwise received a vaccine. Evidence from the review also 
showed that nearly one third of the vaccines were administered outside the traditional working 
day (i.e. evenings, weekends, and holidays), highlighting the unique accessibility of the community 
pharmacy network.  
 
Reviews examining multiple interventions 
Two systematic reviews examined a variety of public health interventions undertaken by 
community pharmacies (Table 6). The review by Blenkinsopp et al. (2003) examined the 
effectiveness of community pharmacy interventions to reduce risk behaviours and risk factors 
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associated with coronary heart disease (smoking cessation, lipid management and blood pressure 
management). The review included 12 relevant studies, which were conducted in the USA, UK, 
Switzerland, Sweden, and Canada. The authors concluded that, through a combination of testing 
and counselling approaches, improvements in health could result from smoking cessation and lipid 
lowering interventions conducted in community pharmacies. Another review, by Brown et al. 
(2016), explored the effectiveness of community pharmacy-delivered interventions for alcohol 
reduction, smoking cessation and weight management. Nineteen relevant studies were included 
from the UK, USA, Australia, Canada, Netherlands, Denmark, Japan and Thailand. Pharmacy-based 
smoking cessation interventions (n=12) including behavioural support and/or nicotine 
replacement therapy were shown to be both effective and cost-effective, particularly when 
compared with usual care. The pooled odds ratio for the intervention effects for smoking 
cessation was 2.56 (95% CI 1.45, 4.53). Evidence from two alcohol-reduction interventions was, 
however, limited, while community pharmacy-based weight management interventions (n=5) 
were shown to be as effective as similar interventions in other primary care settings (at least in the 
short term), and had similar provider costs.  
 
Secondary Prevention 
Screening 
Four systematic reviews examined the impact of screening interventions from a community 
pharmacy setting: one for major diseases (Ayorinde et al., 2013), one on cancer screening (Lindsey 
et al., 2015), and two on osteoporosis screening (Elias et al., 2011; Nguyen, 2017) (Table 7). 
Overall, the results demonstrated that it was feasible to deliver screening interventions from 
community pharmacies, although it was not clear how these interventions impacted on health 
outcomes in terms of early diagnosis of disease. 
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The review by Ayorinde et al. (2013) included 50 relevant studies drawn from the USA, 
Australia, Germany, Korea and Spain. The review focused on a variety of major diseases, including 
cardiovascular, musculoskeletal, diabetes, depression, sleep disorders, respiratory diseases, and 
some cancers. Some screening approaches targeted ‘at risk’ individuals, while others screened an 
apparently healthy population; some interventions did both and targeted normal populations and 
‘at risk’ individuals. The proportion of individuals that screened positively for either disease or 
disease risk factors ranged between 4% and 89%. Although patient satisfaction was high, the 
review authors noted it was common for patients who screened positive to ignore pharmacist 
referral to seek further medical attention in order to confirm the disease diagnosis.  
The second review, by Lindsey et al. (2015), investigated education and screening 
interventions to promote the early detection of cancer (colorectal, prostate, breast and cervical 
cancer). The review included 12 primary studies conducted in the USA, Australia, Italy, Germany, 
Korea, and Spain. The work concluded that, although it was feasible to recruit patients to 
screening interventions in a community pharmacy setting, the interventions were poorly described 
(particularly in terms of delivery, education and fidelity) and that more evidence was needed to 
ascertain how such interventions impact on overall cancer survival.  
Two reviews focused on osteoporosis screening by community pharmacies, both drawing 
from studies in the USA, Canada and Australia. The review by Elias et al. (2011) included three 
primary studies. Interventions were shown to improve the uptake of bone mineral density testing 
(diagnostic test of osteoporosis); people who were identified as being at a high risk of developing 
osteoporosis were also shown to increase their daily calcium intake. A similar review by Nguyen et 
al. (2017) included 11 relevant primary studies, although all but one of the studies was reported in 
the reviews by either Elias et al. (2011) or Ayorinde et al. (2013). This review found community 
pharmacy-based osteoporosis screening services to provide a cost-effective approach to 
preventing osteoporotic fractures for population health. Improvements relating to osteoporosis 
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knowledge, risk identification, and increasing calcium intake were identified as integral 
components of a successful intervention. 
 
 
Chlamydia testing  
Two reviews reported on interventions to promote chlamydia testing (Chlamydia trachomatis) 
through community pharmacies (Table 8), and found a high level of patient acceptance and use. 
The review by Kapadia (2013) focused on assessing chlamydia prevalence, and included eleven 
relevant primary studies conducted in the UK, USA, The Netherlands or Australia; the majority of 
the testing programmes were aimed at people seeking emergency hormonal contraception from 
community pharmacies. The meta-analysis showed a chlamydia positivity of 8.1% (95% CI 7.3-
8.9%) when testing was undertaken in community pharmacies, which was similar to that reported 
from general practices (Adams et al., 2004), but lower than that reported for internet-based 
testing (Gaydos et al., 2011).  
The second review, undertaken by Gudka et al. (2013), included ten relevant studies from 
the USA, UK, Australia and the Netherlands, and compared two different community pharmacy 
approaches to chlamydia testing: (i) population-based screening; and (ii), opportunistic chlamydia 
testing. The review showed that population-based screening had a higher rate of return (38-63%), 
compared to opportunistic testing (12-28%).  
 
Differential effects by demographic or socioeconomic factors 
Out of the fifteen included systematic reviews, seven reviews included studies that 
reported the effects of community pharmacy interventions by demographic or socioeconomic 
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factors (Brown et al., 2016; Burson et al., 2016; Elias et al., 2011; Gudka et al., 2013; Kapadia, 
2013; Lindsey et al., 2015; Nacopoulos et al., 2010).  
Kapedia et al. (2013) examined the profile of patients undertaking chlamydia screening and 
concluded the service was targeted mainly at young people less than 24 years of age, women 
receiving emergency contraception or gay men. One of the included primary studies showed that 
women who were older than 24 years, had received Year 12 or equivalent education, were 
working full-time and were from a less deprived area were more likely to accept the offer of a 
testing kit. This review also highlighted that there were mixed results in terms of uptake of the test 
according to ethnic group. In the other chlamydia screening review by Gudka (2013), 21% and 36% 
of the tests were distributed and purchased by men respectively. In terms of difference in SEPs 
uptake, review-level evidence by Nacopoulos et al. (2010) demonstrated that ethnic minority men 
represented the largest portion of participants using such a service, while women were less likely 
to use the service. The review on cancer screening by Lindsey et al. (2015) identified one primary 
study that examined breast and cervical cancer screening uptake amongst low and moderate 
income women, and concluded community pharmacies could be used to identify ‘at risk’ patients. 
A targeted approach to osteoporosis screening was reported in the review by Elias et al. (2011), 
whereby people living in suburban and rural communities were the main focus of the intervention. 
Burson et al. (2016), who reviewed pharmacy-based immunisation services, showed the impact of 
vaccination uptake on social and geographical inequalities was mixed: some studies showed that 
community pharmacies located in poor and/or ethnically diverse areas were less likely to offer 
inoculation services; these pharmacies also had lower vaccination rates, compared to pharmacies 
located in more affluent areas. However, the review showed there was a broad uptake of 
vaccination services across a variety of ethnic groups. Finally, the review by Brown et al. (2016) 
was unique in comparison to the other included reviews in that it set to explore how the 
interventions effected inequalities in health: whilst none of the included studies reported 
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subgroup analysis of treatment effect by socioeconomic status, three primary studies adopted a 
targeted approach to address inequality and specifically recruited participants from deprived 
areas.  
 
4. Discussion 
This review presents the best available evidence on the effectiveness of community 
pharmacy delivered public health interventions. Fifteen systematic reviews were included in this 
review of reviews, comprising 157 unique primary studies. There are a number of community 
pharmacy initiatives with clear positive intervention effects on primary disease prevention: those 
focusing on smoking cessation, weight management, SEPs, and inoculation services. The 
intervention effects of services focusing on secondary prevention (e.g. screening interventions) 
were less clear, given many studies did not report how such interventions supported the early 
diagnosis of disease. There was limited review-level evidence examining the effects of the 
interventions on health inequalities, as few studies reported sub-group analyses based on the 
PROGRESS-Plus framework. Whilst this may be the result of the systematic reviews failing to 
report all relevant published subgroup outcomes, it is more likely to reflect the primary study 
evidence base not considering outcomes according to PROGRESS-Plus. The majority of the studies 
reporting health inequalities described in this review evaluated targeted interventions (i.e. 
interventions targeted towards people of low SES). Other types of interventions used to target 
health inequalities include interventions focused upon narrowing the gap between the least and 
most disadvantaged (the gap approach), while others can focus on reducing the social gradient in 
health (the gradient approach), although our review did not find any examples of these in the 
literature. Our review has also highlighted limited evidence that suggests some interventions have 
potential to increase health inequalities – potentially leading to so-called ‘intervention generated 
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inequalities’ (Lorenc et al., 2013). One such example was chlamydia testing, whereby older, more 
educated women, from less deprived areas were more likely to access the service.  
This review has many strengths: our search strategy was broad and wide-ranging, which 
included an inclusive database and grey literature search. In addition, no language or date 
restrictions were applied to our search strategy. We also did independent study selection and 
applied a well-validated quality appraisal tool. Consequently, the reviews presented here, and the 
list of primary studies for which they report, detail the health effects for the majority of the 
relevant studies available at the time of our search. 
A limitation of the final included reviews was their study designs, as several did not assess 
the quality of the included primary studies. Furthermore, the differential effects of the 
interventions by demographic or socioeconomic factors was limited, in part due to the reporting 
practices by both the primary study and systematic review authors. Therefore, like all review of 
reviews, we have only synthesised the results of existing systematic reviews and the relevant 
primary studies included within them (Thomson et al., 2018). It is likely that in a number of 
intervention areas, additional primary evaluations have been conducted either after the 
systematic reviews have been completed, or perhaps they did not fit the inclusion criteria for 
systematic reviews. Furthermore, it is possible that there is publication bias (that negative results 
are less likely to be published) with regards to the primary studies. Positive intervention effects in 
primary studies are compounded in systematic reviews (and thus review of reviews) as the 
primary study evidence base may be distorted. This review of reviews is, therefore, a synthesis of 
the findings from published systematic reviews, not a synthesis of all primary studies of such 
interventions. Finally, the included systematic reviews in this review of reviews was focused 
almost exclusively on high-income countries, despite an inclusive PICOS which included studies 
from any country. Only four primary studies were from low or middle income countries (Thailand 
and South Africa) representing 2.5% of the unique primary studies identified here. In view of this, 
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the findings from this review of reviews are not necessarily transferable to community pharmacies 
located in low or middle income countries and further primary studies and subsequent reviews 
should seek to address this important gap.  
This review supports the policy shift of community pharmacies delivering public health 
programmes to improve health, and prevent disease – particularly those aimed at primary 
prevention. It is clear that any future initiatives regarding community pharmacy and public health 
should be underpinned by the best available evidence; for example, previous community 
pharmacy campaigns have employed interventions focused on reducing alcohol misuse when the 
literature suggests such interventions have no impact on health or health behaviour.  
This work also highlighted some important gaps in the literature regarding community 
pharmacy and public health services. The majority of the included systematic reviews included 
interventions directed towards physical health; there were no systematic reviews that exclusively 
focused on public mental health interventions. We note that a number of primary studies have 
been undertaken exploring the role of the community pharmacist in screening for depression (see, 
for example, (Kondova et al., 2018; Wilson and Twigg, 2018)), with others focusing on 
interventions preventing the development of depression (ISRCTN registry, 2017), but as yet, no 
systematic reviews have explored the effect of community pharmacy-based services on public 
mental health. Given the association between mental and physical health, and that mental health 
conditions are a significant cause of overall disease burden worldwide, it would be sensible for 
future systematic reviews to explore this. 
5. Conclusions 
This review supports the development of some community pharmacy public health services – 
particularly those focused on the primary disease prevention. At present, little is known how 
community pharmacy-delivered public health interventions impact on health inequalities. It would 
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be prudent for future studies to address this by explicitly reporting outcomes according to the 
PROGRESS-Plus framework. 
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Figure 1: PRISMA flow diagram. 
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Table 1: Summary of systematic reviews exploring the effects of smoking cessation interventions. 
Study No. of relevant 
studies 
(number of 
articles if 
different) 
Context 
(country, 
search 
timeframe) 
Intervention(s) If more than 1 intervention, 
enter n of studies 
Summary of results Health inequalities assessed/ 
reported 
Quality rating of 
review 
Sinclair et al. 
(2004)  
2 (6) Northern 
Ireland and 
Scotland; search 
timeframe from 
inception to 
October 2007. 
Smoking cessation intervention involving 
training with the Stages of Change Model 
and a support programme of counselling 
and record keeping. 
Two studies were duplicated in Saba et al. 
(2014). Two studies were duplicated in 
Brown et al. (2016). Two studies were 
duplicated in Blenkinsopp et al. (2003). 
One study reported a significant 
effect in self-reported cessation 
rates at 12 months. The other 
study showed a positive but non-
significant effect at 9 months. 
Not mentioned as an outcome in 
the review. 
No health inequality data 
presented.  
1 
Saba et al. 
(2014)  
5 USA, UK and 
Sweden; 
searches from 
inception to 
May 2013. 
Smoking cessation intervention providing 
advice and counselling to patients, either 
on a one-to-one basis or within group 
sessions (one study offered nicotine 
replacement therapy (NRT) in addition). 
Two studies were duplicated in Sinclair et 
al. (2004). Three reviews were duplicated in 
Blenkinsopp et al. (2003). Three reviews 
were duplicated also in Brown et al. (2016). 
Smoking cessation interventions 
resulted in better abstinence 
rates as compared with controls 
(RR 2.17, 95% CI 1.43, 3.31). The 
use of NRT and biochemical 
validation yielded higher 
abstinence rates. 
Not mentioned as an outcome in 
review. 
No health inequality data 
presented. 
4 
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Table 2: Summary of systematic reviews on weight management programmes.  
Study No. of 
relevant 
studies 
(number of 
articles if 
different) 
Context (country, 
search timeframe) 
Intervention(s)  Summary of results Health inequalities assessed/ 
reported 
Quality of 
review 
Gordon et al. 
(2011)  
10 (12) USA, UK, 
Switzerland, Spain, 
Denmark; searches 
from January 1999 
to June 2009. 
Weight management interventions 
delivered in community pharmacy settings. 
One study was duplicated in Brown et al. 
(2016). 
Weight management 
interventions can produce 
modest but significant weight 
loss. Two studies reported 
clinically significant weight loss at 
3-6 months, three studies 
reported weight losses between 
1.1-4.1 kg at one year. 
Not mentioned as an outcome in 
review. 
No subgroup analysis reported 
based on inequalities. 
2 
 
Table 3: Summary of systematic reviews on alcohol misuse. 
Study No. of 
relevant 
studies 
(number of 
articles if 
different) 
Context (country, 
search timeframe) 
Intervention(s)  Summary of results Health inequalities assessed/ 
reported 
Quality of 
review 
Watson and 
Blenkinsopp 
(2009)  
2 (4) UK; searches from 
1996 to 2007. 
Using screening tools (AUDIT/FAST) to 
identify hazardous and harmful drinkers 
and offering advice to reduce 
consumption. 
Non-significant reductions in 
alcohol consumption. 
Not mentioned as an outcome in 
review. 
No health inequality data 
presented. 
4 
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Table 4: Summary of systematic reviews on syringe/needle exchange programmes. 
Study No. of 
relevant 
studies 
(number 
of articles 
if 
different) 
Context (country, 
search timeframe) 
Intervention(s)  Summary of results Health inequalities assessed/ 
reported 
Quality of 
review 
Nacopoulos et 
al. (2010) 
16 USA; included studies 
published since 2000. 
Pharmacy-based SEPs. 
One study was duplicated in Sawangjit et 
al. (2016). 
 
Shown to improve the health 
outcomes of injection drug users 
by decreasing the transmission of 
blood-borne disease and 
lowering high-risk injective 
behaviours. 
Not mentioned as an outcome in 
review. 
Minority men represent the 
largest portion of participants of 
SEPs. Women appear to be under 
represented among SEP 
participants.  
5 
Sawangjit et 
al. (2016)  
13 USA, Australia, Estonia, 
Canada and the UK; 
searches from inception 
to January 2016. 
Pharmacy-based syringe exchange 
programmes (SEPs). 
One study was duplicated in Nacopoulos et 
al. (2010). 
 
Pharmacy SEPs appear to be 
effective for reducing risk 
behaviours among people who 
inject drugs, although their effect 
on HIV/Hepatitis C prevalence 
and economic outcomes is 
unclear. Sharing-syringe 
behaviour was significantly better 
in pharmacy-based SEPs 
compared to no SEPs. For all 
studies the odds ratio was 0.50 
(95% CI = 0.34, 0.73; I
2
 = 59.6%). 
The odds ratio was 0.52 (95% CI = 
0.32-0.84; I
2
 = 41.4%) when 
excluding studies with a high risk 
of bias. 
Not mentioned as an outcome in 
review. 
No health inequality data 
presented. 
2 
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Table 5: Summary of systematic reviews on inoculation services. 
Study No. of 
relevant 
studies 
(number 
of articles 
if 
different) 
Context (country, 
search timeframe) 
Intervention(s)  Summary of results Health inequalities assessed/ 
reported 
Quality of 
review 
Burson et al. 
(2016)  
17 USA (and one based in 
Puerto Rico); searches 
from 1992 to 2016. 
Pharmacy-based Inoculation Service (PBIS).  Review provides evidence that 
PBIS increases vaccination rates, 
and are more accessible to 
medically underserved 
populations, especially when 
compared to physician-based 
vaccinations.  
Not mentioned as an outcome in 
review. 
Few studies examined health 
inequalities. One primary study 
showed that pharmacies located 
in poor and/or ethnically diverse 
areas were both less likely to 
offer inoculation services and 
have a lower vaccination rates. 
However, another study 
demonstrated that different 
ethnicities who collected 
prescriptions at community 
pharmacies had higher 
vaccination rates compared to 
respondents who did not.  
5 
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Table 6: Summary of systematic reviews on multi-targeted interventions. 
Study No. of 
relevant 
studies 
(number 
of articles 
if 
different) 
Context (country, 
search timeframe) 
Intervention(s)  Summary of results Health inequalities assessed/ 
reported 
Quality of 
review 
Blenkinsopp 
et al. (2003) 
12 (14) USA, UK, Switzerland, 
Sweden, Canada; 
searches from 1990 to 
2001. 
Pharmacy-based activity in the reduction of 
risk behaviours and risk factors for 
coronary heart disease (smoking cessation 
and lipid-lowering treatments). 
Interventions include, counselling, advice, 
cholesterol screening, lip, blood pressure 
and weight management. 
Two studies were duplicated in Ayorinde et 
al. (2013). Three reviews were duplicated in 
Saba et al. (2014). Two studies were 
duplicated in Brown et al. (2016). 
Two studies were duplicated in Sinclair et 
al. (2004). 
Review highlighted the clinical 
and cost-effectiveness of 
community pharmacies in 
smoking cessation and lipid 
management.  
Not mentioned as an outcome in 
review. 
No health inequality data 
presented. 
3 
Brown et al. 
(2016) 
Narrative 
synthesis: 
19 (23*) 
 
Meta-
analysis: 
10 
UK, USA, Australia, 
Canada, the 
Netherlands, Japan, 
Denmark; searches 
from inception to May 
2014. 
Alcohol reduction (brief advice) (n=2); 
smoking cessation (NHS smoking cessation 
service, NRT, training for pharmacists, 
advice giving, behavioural 
counselling/support) (n=12); Weight 
management (n=5) (meal replacement, low 
calorie diet, diet and physical activity, 
orlistat plus support, individual or group 
support). 
Two studies were duplicated in Sinclair et 
al. (2004). Three reviews were duplicated 
also in Saba et al. (2014). One review was 
duplicated in Gordon et al. (2011). Two 
reviews were duplicated in Blenkinsopp et 
al. (2003). 
Insufficient evidence to assess 
the effectiveness of community 
pharmacy-based interventions 
for alcohol reduction. 
Smoking cessation interventions 
are effective and cost effective, 
particularly when compared with 
usual care. 
Weight management 
interventions appear to be as 
ineffective as similar 
interventions in other health care 
settings, although have similar 
provider costs. 
Mentioned as an outcome in 
review. 
Three primary studies adopted a 
targeted approach (recruiting 
participants from deprived 
areas). Two studies involving 
weight management and 
smoking cessation, found there 
were demographic and 
socioeconomic differences 
between participants who self-
selected treatment by setting. 
2 
*Although review states 19 studies were included from 23 articles, only 19 references are included in text/tables and therefore reported here in total number of primary studies. 
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Table 7: Summary of systematic reviews on screening programmes. 
Study No. of 
relevant 
studies 
(number 
of articles 
if 
different) 
Context (country, 
search timeframe) 
Intervention(s)  Summary of results Health inequalities assessed/ 
reported 
Quality of 
review 
Ayorinde et 
al. (2013) 
50 (51) Various (USA, Australia, 
UK, Thailand, 
Switzerland, Spain, 
Canada, South Africa, 
Ireland); searches from 
1990 to August 2012. 
A range of screening tools including 
questionnaires or risk assessment forms, 
medical equipment and psychological 
measurements. A range of diseases were 
assessed including cardiovascular risk 
factors, musculoskeletal diseases, diabetes 
or diabetes risk factors, depression, sleep 
disorders, respiratory diseases, colon, 
breast or bowel cancer. 
Three studies were duplicated in Lindsey et 
al. (2015). Eight studies were duplicated in 
Nguyen (2017). Two studies were 
duplicated in Elias et al. (2011). Two studies 
were duplicated in Blenkinsopp et al. 
(2003).  
 
The evidence suggests that 
screening for some diseases in 
community pharmacies is 
feasible, although the quality of 
many of the studies is poor. 
Between 4 and 89% of screened 
individual identified with disease 
risk factors.  
Not mentioned as an outcome in 
review.  
No health inequality data 
presented. 
4 
Lindsey et al. 
(2015) 
12 Various (US, Australia, 
Italy, Germany, Korea 
and Spain); searches 
from inception to June 
2015. 
Educational interventions (n=4) 
Three focused on educating women about 
breast and cervical cancer and a fourth 
study on colorectal cancer investigated 
educational handouts and advice versus 
screening.  
Screening interventions (n=10) 
Six studies used a test kit and four studies 
provided screening through questionnaires 
or checklists. 
Three studies were duplicated in Ayorinde 
Review demonstrates scope to 
use community pharmacies as a 
setting to deliver education and 
screening early cancer detection 
interventions. The studies, which 
focused on a variety of different 
cancers, showed it was feasible 
to recruit patients to these 
interventions, however the 
primary studies were poorly 
described. 
Not mentioned as an outcome in 
review.  
Reported one primary study 
which looked at breast and 
cervical cancer screening in low 
and moderate income women 
and concluded community 
pharmacies could be used to 
identify ‘at risk’ patients and to 
refer them on for further 
investigation. 
3 
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et al. (2013). 
 
Elias et al. 
(2011) 
3 Australia, the US and 
Canada; searches 
conducted up to April 
2010. 
A range of enhanced care for osteoporosis 
management interventions were utilised 
including education, bone mineral density 
testing, medication reviews and a heel 
quantitative ultrasound. 
Two studies were duplicated in Ayorinde et 
al. (2013). Two studies were duplicated in 
Nguyen (2017). 
 
 
Mixed results highlighted: one 
study showed no significant 
difference between groups, one 
found significant improvements 
(though the results could have 
been influenced by a high level of 
bias) and the final study found 
significant improvements for 
intervention group with a low risk 
of bias. 
Not mentioned as an outcome in 
review. 
One primary study was targeted 
at suburban and rural 
communities only. 
1 
Nguyen et al. 
(2017) 
9 USA, Canada, Australia; 
search timescale not 
specified. 
Osteoporosis screening by dual X-ray 
absorptiometry (DXA) and/or quantitative 
ultrasound with one study that used 
peripheral instantaneous X-ray (PIXI) that 
uses DXA technology. Osteoporosis 
education and/or counselling was offered 
in addition in most of the studies. 
Two studies were duplicated in Elias et al. 
(2011). Eight studies were duplicated in 
Ayorinde et al. (2013). 
 
 
Community osteoporosis 
screening services showed 
positive outcomes in 
osteoporosis identification, risk 
identification, calcium intake, 
service satisfaction, primary care 
physician perspective, and 
financial sustainability.  
Not mentioned as an outcome in 
review. 
No health inequality data 
presented. 
5 
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Table 8: Summary of systematic reviews on chlamydia testing. 
Study No. of 
relevant 
studies 
(number 
of articles 
if 
different) 
Context (country, 
search timeframe) 
Intervention(s)  Summary of results Health inequalities assessed/ reported Quality 
of 
review 
Kapadia 
(2013) 
11 UK, USA, Netherlands 
and Australia; searches 
from 1995 to June 
2011. 
Chlamydia screening offered mainly to 
women attending an emergency 
contraception appointment or displaying 
self-test kits which were offered to clients 
presenting for any sex-related product or 
consultation. 
 
Eight studies were duplicated in Gudka et 
al. (2013). 
 
The reported acceptance of 
chlamydia screening was 
between 10 and 47%. The 
proportion subsequently who 
returned a kit was between 12-
64%. 
 
Meta-analysis demonstrated a 
chlamydia positivity of 8.1% 
(95%CI 7.3, 8.9%). 
 
Not mentioned as an outcome in review. 
Reported that young women were more 
likely to be reached than young men. 
Also, women who were older than 24 
years old, who had received the 
minimum Year 12 or equivalent 
qualification, were working full-time and 
were from a less deprived area were 
more likely to accept the offer of a 
screening kit. With regards preferential 
uptake by ethnic minorities, the evidence 
was mixed. 
5 
Gudka et al. 
(2013) 
10 UK, Australia, USA and 
the Netherlands; 
searches up to October 
2011. 
Consumers could request a chlamydia test 
as part of a population-based intervention 
(n=3), or pharmacists could offer a 
chlamydia test to consumers attending the 
pharmacy for a sexual health-related 
consultation (opportunistic screening, 
n=4). Some studies used both population-
based and opportunistic chlamydia 
screening. 
 
Eight studies were duplicated in Kapadia 
(2013). 
 
The rate of return was greatest 
for population-based chlamydia 
testing (38-63.9%). Opportunistic 
screening was generally lower, 
with a rate of return between 12 
and 28%.  
Not mentioned as an outcome in review. 
Five of the pharmacy-based chlamydia 
screening interventions targeted men as 
well as women. Two studies from the UK 
showed that 21% of the tests distributed 
and 36% of the tests purchased were 
from men. 
3 
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Highlights 
 Community pharmacies deliver a range of public health services. 
 Our work identified 15 systematic reviews comprising 157 primary unique studies. 
 There were a number of services with positive effects on health outcomes. 
 Very few reviews examined health inequality effects. 
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